📊 CCRN Key Takeaways
Is Cross Country Healthcare Inc. (CCRN) a Good Investment?
Cross Country Healthcare faces severe operational headwinds with negative operating and net income coupled with a sharp 21.6% YoY revenue decline, indicating structural challenges in the healthcare staffing market. While the strong balance sheet ($105.6M cash, zero long-term debt, 3.29x current ratio) provides financial cushion, the company's deteriorating profitability and low gross margins (19.9%) suggest fundamental business pressures that balance sheet strength alone cannot offset. The positive operating cash flow offers limited reassurance given the sustained unprofitability and revenue erosion trajectory.
Cross Country Healthcare's fundamentals show a materially weakened earnings profile, with revenue down 21.6% year over year and margins deeply negative, indicating that the business is currently struggling to convert scale into profitability. While the balance sheet is strong with substantial cash, no long-term debt, and positive free cash flow, those strengths mainly provide stability rather than evidence of healthy operating momentum.
Cross Country Healthcare Inc. Key Strengths (CCRN)
- Fortress balance sheet with $105.6M cash and zero long-term debt reduces financial distress risk
- Exceptional liquidity position with 3.29x current ratio provides runway for operational improvements
- Positive operating cash flow of $4.8M and positive free cash flow despite accounting losses indicate some operational viability
- Strong liquidity with a 3.78x current and quick ratio
- Debt-free balance sheet with $108.74M in cash and no long-term debt
- Positive operating cash flow and free cash flow despite net losses
CCRN Stock Risks: Cross Country Healthcare Inc. Investment Risks
- Severe revenue contraction of 21.6% YoY suggests loss of market share or demand collapse in healthcare staffing services
- Persistent operating losses (-4.2M) and negative net income with negative margins indicate structural unprofitability, not cyclical headwinds
- Deteriorating gross margins at 19.9% combined with inability to control costs despite lower revenue volume signal pricing pressure and operational inefficiency
- Sharp revenue contraction suggests weak demand or pricing pressure
- Negative operating and net margins indicate severe profitability deterioration
- Large net loss and negative returns on assets and equity raise concerns about earnings quality and capital efficiency
Key Metrics to Watch
- Quarterly revenue stabilization/recovery - current -21.6% YoY decline is unsustainable
- Gross margin trend and cost structure management to return to operational profitability
- Operating cash flow sustainability as the primary indicator of actual business health versus accounting metrics
- Revenue trend and gross margin recovery
- Operating cash flow relative to net income and operating margin
Cross Country Healthcare Inc. (CCRN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 1.4% FCF margin may limit capital allocation flexibility. Strong liquidity with a 3.29x current ratio provides a solid financial cushion.
CCRN Profit Margin, ROE & Profitability Analysis
CCRN vs Services Sector: How Cross Country Healthcare Inc. Compares
How Cross Country Healthcare Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cross Country Healthcare Inc. Stock Overvalued? CCRN Valuation Analysis 2026
Based on fundamental analysis, Cross Country Healthcare Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cross Country Healthcare Inc. Balance Sheet: CCRN Debt, Cash & Liquidity
CCRN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cross Country Healthcare Inc.'s revenue has grown significantly by 20% over the 5-year period, indicating strong business expansion. The most recent EPS of $2.05 reflects profitable operations.
CCRN Revenue Growth, EPS Growth & YoY Performance
CCRN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $241.1M | -$490.0K | $-0.02 |
| Q3 2025 | $250.1M | $2.6M | $0.08 |
| Q2 2025 | $274.1M | -$6.7M | $-0.20 |
| Q1 2025 | $293.4M | -$490.0K | $-0.02 |
| Q3 2024 | $315.1M | $2.6M | $0.08 |
| Q2 2024 | $339.8M | -$13.4M | $-0.39 |
| Q1 2024 | $379.2M | $2.7M | $0.08 |
| Q3 2023 | $442.3M | $12.8M | $0.36 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cross Country Healthcare Inc. Dividends, Buybacks & Capital Allocation
CCRN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cross Country Healthcare Inc. (CIK: 0001141103)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CCRN
What is the AI rating for CCRN?
Cross Country Healthcare Inc. (CCRN) has a Combined AI Grade of C from Claude (C) and ChatGPT (C) with 77% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CCRN's key strengths?
Claude: Fortress balance sheet with $105.6M cash and zero long-term debt reduces financial distress risk. Exceptional liquidity position with 3.29x current ratio provides runway for operational improvements. ChatGPT: Strong liquidity with a 3.78x current and quick ratio. Debt-free balance sheet with $108.74M in cash and no long-term debt.
What are the risks of investing in CCRN?
Claude: Severe revenue contraction of 21.6% YoY suggests loss of market share or demand collapse in healthcare staffing services. Persistent operating losses (-4.2M) and negative net income with negative margins indicate structural unprofitability, not cyclical headwinds. ChatGPT: Sharp revenue contraction suggests weak demand or pricing pressure. Negative operating and net margins indicate severe profitability deterioration.
What is CCRN's revenue and growth?
Cross Country Healthcare Inc. reported revenue of $241.1M.
Does CCRN pay dividends?
Cross Country Healthcare Inc. does not currently pay dividends.
Where can I find CCRN SEC filings?
Official SEC filings for Cross Country Healthcare Inc. (CIK: 0001141103) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CCRN's EPS?
Cross Country Healthcare Inc. has a diluted EPS of $-0.14.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is CCRN's fundamental grade?
Based on our AI fundamental analysis in June 2026, Cross Country Healthcare Inc. has a C grade with 77% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is CCRN stock overvalued or undervalued?
Valuation metrics for CCRN: ROE of -1.4% (sector avg: 16%), net margin of -1.8% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is CCRN's AI grade for 2026?
Our dual AI analysis gives Cross Country Healthcare Inc. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CCRN's free cash flow?
Cross Country Healthcare Inc.'s operating cash flow is $4.8M, with capital expenditures of $1.5M. FCF margin is 1.4%.
How does CCRN compare to other Services stocks?
Vs Services sector averages: Net margin -1.8% (avg: 10%), ROE -1.4% (avg: 16%), current ratio 3.29 (avg: 1.5).